December 1992

Nuclear DNA Analysis of Hyperplastic Parathyroid Glands in Multiple Endocrine Neoplasia Type I

Author Affiliations

From the Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan (Dr Komatsu); the Department of Pathology, Maine Medical Center, Portland (Dr Nishiyama); and Maine Cytometry Research Institute, South Portland (Dr Bagwell).

Arch Surg. 1992;127(12):1430-1434. doi:10.1001/archsurg.1992.01420120064012

• Twenty-four hyperplastic parathyroid glands from 11 patients with multiple endocrine neoplasia type I (MEN-I), and 36 hyperplastic parathyroid glands in 15 patients with sporadic primary hyperparathyroidism, ie, not associated with MEN, were analyzed for DNA by flow cytometry. Sixteen of 24 hyperplastic parathyroid glands from patients with MEN-I were DNA diploid, and eight were DNA aneuploid. Thirty-three of 36 hyperplastic parathyroid glands from patients without MEN were DNA diploid, and only three were DNA aneuploid. The mean percentage of 4c level (a measure of the G2M phase of the cell cycle) of DNA diploid hyperplastic parathyroid glands taken from patients with MEN-I was 8.1%±4.5%, which is significantly higher than the 3.5%±3.4% for those taken from patients without MEN. Our results show that there is a difference in nuclear DNA content between hyperplastic parathyroid glands in patients with MEN-I and those in patients without MEN.

(Arch Surg. 1992;127:1430-1434)